Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gadopentetic acid (gadolinium complex) (Gd-DTPA) is an paramagnetic contrast agent commonly implemented by a bolus intravenous injection (i.v.) in Dynamic contrast-enhanced MRI (DCE-MRI) studies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 41.00 |
Description | Gadopentetic acid (gadolinium complex) (Gd-DTPA) is an paramagnetic contrast agent commonly implemented by a bolus intravenous injection (i.v.) in Dynamic contrast-enhanced MRI (DCE-MRI) studies. |
In vivo | The initial concentration of Gadopentetic acid (Gd-DTPA) in the plasma ([Gd-DTPA0]) is an important parameter for DCE-MRI.?[Gd-DTPA0] is related to the administered bolus dose and varies with subjects.?A bolus of 0.025 mmol/kg Gd-DTPA offers shorter acquisition time and less exposure of subjects, with a half-life of 37.3 mins, a mean residence time of 53.8 mins, and an AUC of 3.37 ± 0.47 mmol/min/L. |
Synonyms | gadolinium complex, Gd-DTPA |
Molecular Weight | 547.57 |
Formula | C14H20GdN3O10 |
CAS No. | 80529-93-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 100 mg/mL (182.63 mM), Sonication is recommended.
DMSO: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gadopentetic acid 80529-93-7 Others Inhibitor intravenous injection paramagnetic contrast nephrogenic systemic fibrosis (NSF) gadolinium complex inhibit Gd-DTPA inhibitor